You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

BACITRACIN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for bacitracin and what is the scope of patent protection?

Bacitracin is the generic ingredient in twenty branded drugs marketed by Pharmacia And Upjohn, Lilly, Padagis Us, Pharmaderm, Pharmafair, Combe, Naska, X Gen Pharms, Apothekernes, Paddock Llc, Casper Pharma Llc, Bausch And Lomb, Sciegen Pharms Inc, Monarch Pharms, Dow Pharm, Glaxosmithkline, and Altana, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for bacitracin. One supplier is listed for this compound.

Summary for BACITRACIN
US Patents:0
Tradenames:20
Applicants:17
NDAs:37
Drug Master File Entries: 27
Finished Product Suppliers / Packagers: 1
Clinical Trials: 31
Drug Prices: Drug price trends for BACITRACIN
What excipients (inactive ingredients) are in BACITRACIN?BACITRACIN excipients list
DailyMed Link:BACITRACIN at DailyMed
Drug Prices for BACITRACIN

See drug prices for BACITRACIN

Recent Clinical Trials for BACITRACIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State UniversityN/A
Cairo UniversityEarly Phase 1
University of Turin, ItalyN/A

See all BACITRACIN clinical trials

Pharmacology for BACITRACIN
Medical Subject Heading (MeSH) Categories for BACITRACIN

US Patents and Regulatory Information for BACITRACIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
X Gen Pharms ZIBA-RX bacitracin zinc POWDER;FOR RX COMPOUNDING 061737-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 064046-001 Jan 26, 1995 AT RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline POLYSPORIN bacitracin zinc; polymyxin b sulfate AEROSOL;TOPICAL 050167-002 Mar 1, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Naska BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;TOPICAL 062833-001 Nov 9, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.